Memorial Sloan Kettering Cancer Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT00588341
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer
Completed
- Conditions
- CounselingBreast Cancer
- Interventions
- Behavioral: focus group & questionaire
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT00588705
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Study of D-Methadone in Patients With Chronic Pain
Phase 1
Completed
- Conditions
- PainCNS CancerEye CancerOtorhinolaryngologic NeoplasmsBladder CancerEsophageal CancerPancreatic CancerBreast CancerColon CancerProstate Cancer
- Interventions
- Drug: placebo
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00588640
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA
Completed
- Conditions
- OncologyPediatric Cancers
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2013-10-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 102
- Registration Number
- NCT00588289
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Estrogen, Diet, Genetics and Endometrial Cancer
Active, not recruiting
- Conditions
- CancerEndometrial CancerCorpus UteriOvarian CancerEndometrium
- Interventions
- Behavioral: Questionnaire
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 1315
- Registration Number
- NCT00587886
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
Completed
- Conditions
- Osteosarcoma
- Interventions
- Other: Blood draw
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2011-09-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 59
- Registration Number
- NCT00588510
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
AIDS and Cancer Specimen Bank (ACSB)
Completed
- Conditions
- Kaposi's Sarcoma ClassicalNon-Hodgkin's LymphomaKaposi's Sarcoma AIDS RelatedAIDSHEMATOPOIETIC SYSTEMCancer
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2011-04-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 65
- Registration Number
- NCT00587912
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
Not Applicable
Completed
- Conditions
- Breast CancerOsteoporosis
- Interventions
- Other: Bone Mineral Density
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2009-02-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT00587925
- Locations
- 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases
Completed
- Conditions
- Colorectal Carcinoma
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2009-03-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 204
- Registration Number
- NCT00588549
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)
Phase 2
Completed
- Conditions
- Hodgkin's Disease
- Interventions
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2009-06-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00587873
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States